Literature DB >> 8609632

Solution structure of the N-terminal RNP domain of U1A protein: the role of C-terminal residues in structure stability and RNA binding.

J M Avis1, F H Allain, P W Howe, G Varani, K Nagai, D Neuhaus.   

Abstract

The solution structure of a fragment of the human U1A spliceosomal protein containing residues 2 to 117 (U1A117) determined using multi-dimensional heteronuclear NMR is presented. The C-terminal region of the molecule is considerably more ordered in the free protein than thought previously and its conformation is different from that seen in the crystal structure of the complex with U1 RNA hairpin II. The residues between Asp90 and Lys98 form an alpha-helix that lies across the beta-sheet, with residues IIe93, IIe94 and Met97 making contacts with Leu44, Phe56 and IIe58. This interaction prevents solvent exposure of hydrophobic residues on the surface of the beta-sheet, thereby stabilising the protein. Upon RNA binding, helix C moves away from this position, changing its orientation by 135 degrees to allow Tyr13, Phe56 and Gln54 to stack with bases of the RNA, and also allowing Leu44 to contact the RNA. The new position of helix C in the complex with RNA is stabilised by hydrophobic interactions from IIe93 and IIe94 to IIe58, Leu 41, Val62 and His 10, as well as a hydrogen bond between Ser91 and Thr11. The movement of helix C mainly involves changes in the main-chain torsion angles of Thr89, Asp90 and Ser91, the helix thereby acting as a "lid" over the RNA binding surface.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609632     DOI: 10.1006/jmbi.1996.0171

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  66 in total

1.  Key residues revealed in a major conformational epitope of the U1-70K protein.

Authors:  E Welin Henriksson; M Wahren-Herlenius; I Lundberg; E Mellquist; I Pettersson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  Molecular dynamics simulations of the complex between human U1A protein and hairpin II of U1 small nuclear RNA and of free RNA in solution.

Authors:  Y Tang; L Nilsson
Journal:  Biophys J       Date:  1999-09       Impact factor: 4.033

Review 3.  Macromolecular mimicry.

Authors:  P Nissen; M Kjeldgaard; J Nyborg
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

4.  Fourteen residues of the U1 snRNP-specific U1A protein are required for homodimerization, cooperative RNA binding, and inhibition of polyadenylation.

Authors:  J M Klein Gunnewiek; R I Hussein; Y van Aarssen; D Palacios; R de Jong; W J van Venrooij; S I Gunderson
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  From snapshot to movie: phi analysis of protein folding transition states taken one step further.

Authors:  T Ternström; U Mayor; M Akke; M Oliveberg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

6.  Molecular dynamics studies of U1A-RNA complexes.

Authors:  C M Reyes; P A Kollman
Journal:  RNA       Date:  1999-02       Impact factor: 4.942

7.  Investigation of a conserved stacking interaction in target site recognition by the U1A protein.

Authors:  Jerome C Shiels; Jacob B Tuite; Scott J Nolan; Anne M Baranger
Journal:  Nucleic Acids Res       Date:  2002-01-15       Impact factor: 16.971

8.  Substitution of an essential adenine in the U1A-RNA complex with a non-polar isostere.

Authors:  Jacob B Tuite; Jerome C Shiels; Anne M Baranger
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

9.  Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein.

Authors:  José Manuel Pérez Cañadillas; Gabriele Varani
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

10.  Determinants within an 18-amino-acid U1A autoregulatory domain that uncouple cooperative RNA binding, inhibition of polyadenylation, and homodimerization.

Authors:  Fei Guan; Daphne Palacios; Reem I Hussein; Samuel I Gunderson
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.